Welcome to our dedicated page for Capstone Holding SEC filings (Ticker: CAPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Capstone Holding Corp鈥檚 filings can feel like two companies in one鈥攃linical trials for an FDA-designated peptide drug on one page, stone cladding revenue on the next. If you have ever searched for 鈥淐apstone Holding Corp SEC filings explained simply鈥� or wondered how to track 鈥淐apstone Holding Corp insider trading Form 4 transactions,鈥� you know the challenge. Our platform removes that complexity.
Stock Titan鈥檚 AI reads every 10-K, 10-Q, 8-K and proxy so you don鈥檛 have to. Need the biotech pipeline risks buried deep in the 鈥淩isk Factors鈥� section? Our summaries surface them in plain English. Looking for construction-segment margins in the 鈥淢D&A鈥� of a 鈥淐apstone Holding Corp quarterly earnings report 10-Q filing鈥�? They鈥檙e highlighted and charted. AG真人官方-time alerts flag 鈥淐apstone Holding Corp Form 4 insider transactions real-time,鈥� letting you monitor executive stock moves minutes after they hit EDGAR. You can also review 鈥淐apstone Holding Corp 8-K material events explained鈥� or dive into the 鈥淐apstone Holding Corp proxy statement executive compensation鈥� table without scrolling through hundreds of pages.
Whether you鈥檙e comparing trial milestones across years, mapping stone sales by region, or seeking a 鈥淐apstone Holding Corp annual report 10-K simplified,鈥� our AI-powered analysis delivers. Investors use these tools to spot revenue shifts between segments, evaluate dilution risk linked to drug development, and time decisions based on 鈥淐apstone Holding Corp earnings report filing analysis.鈥� Transparent data, expert context, and real-time updates鈥攁ll in one place.
On June 30, 2025, Capstone Holding Corp. (NASDAQ: CAPS) filed a Form 8-K to report an “Other Events” item. The company disclosed that it issued a same-day press release announcing the publication of an investor FAQ. The filing furnishes that press release as Exhibit 99.1 and lists the Cover Page Interactive Data File as Exhibit 104. No financial results, strategic transactions, leadership changes, or guidance updates are contained in the submission, suggesting the event is primarily informational and routine.
Capstone Holding (Nasdaq: CAPS) filed an 8-K announcing a first amendment to its May 14 2025 common-stock purchase agreement with Tumim Stone Capital.
- Raises the single VWAP Purchase limit to $3 million (from $2 million)
- Eliminates the 100% five-day average volume restriction; new ceiling is the lesser of 40% same-day volume or $3 million divided by prior-day VWAP
- Aggregate facility size remains up to $20 million; shares still priced at 97% of the lowest three-day VWAP
The amendment provides faster, larger draws for working-capital needs but may accelerate dilution and trading pressure because more shares can be issued below market in a single transaction.
FAQ
What is the current stock price of Capstone Holding (CAPS)?
What is the market cap of Capstone Holding (CAPS)?
What are the primary business segments of Capstone Holding Corp?
What is the focus of Capstone鈥檚 biotechnology segment?
How does the construction materials segment operate?
What makes Capstone's approach unique in its biotechnology initiatives?
How does Capstone Holding Corp manage its tax attributes?
What role does TotalStone, LLC play in the company鈥檚 structure?
How does Capstone maintain corporate governance?
How does Capstone differentiate itself from competitors?
